Cargando…
Variation in transcriptional regulation of cyclin dependent kinase inhibitor p21(waf1/cip1 )among human bronchogenic carcinomas
BACKGROUND: Cell proliferation control depends in part on the carefully ordered regulation of transcription factors. The p53 homolog p73, contributes to this control by directly upregulating the cyclin dependent kinase inhibitor, p21(waf1/cip1). E2F1, an inducer of cell proliferation, directly upreg...
Autores principales: | Harr, Michael W, Graves, Timothy G, Crawford, Erin L, Warner, Kristy A, Reed, Cheryl AM, Willey, James C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1185562/ https://www.ncbi.nlm.nih.gov/pubmed/16014176 http://dx.doi.org/10.1186/1476-4598-4-23 |
Ejemplares similares
-
Stable low-level expression of p21(WAF1/CIP1 )in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control
por: Graves, Timothy G, et al.
Publicado: (2006) -
Reciprocal role of cyclins and cyclin kinase inhibitor p21(WAF1/CIP1 )on lymphocyte proliferation, allo-immune activation and inflammation
por: Khanna, Ashwani K
Publicado: (2005) -
The cyclin dependent kinase inhibitor p21(Cip1/Waf1) is a therapeutic target in high-risk neuroblastoma
por: Sorteberg, Agnes Luise, et al.
Publicado: (2022) -
Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
por: Shi, Y., et al.
Publicado: (1996) -
The Role of the Cyclin Dependent Kinase Inhibitor p21(cip1/waf1) in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics
por: Al Bitar, Samar, et al.
Publicado: (2019)